This inventor holds 0 USPTO granted patents, plus 6 CIPO patents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Title: Pan Zeng - Innovator in Hematologic Cancer Treatment
Introduction
Pan Zeng is an accomplished inventor based in the United States, known for his contributions to the field of hematologic cancer treatment. His innovative work focuses on the use of Hypoxia-Inducible Factor (HIF) inhibitors, which have the potential to revolutionize cancer therapy.
Latest Patents
Although Pan Zeng currently holds no patents, his notable invention involves the use of HIF inhibitors for treating hematologic cancers. This invention specifically addresses the induction of acute myeloid leukemia remission and the inhibition of cancer stem cell survival functions.
Career Highlights
Pan Zeng is associated with Oncoimmune, Inc., a company dedicated to advancing cancer treatment through innovative therapies. His work at Oncoimmune highlights his commitment to improving patient outcomes in the field of oncology.
Collaborations
Pan Zeng collaborates with esteemed colleagues, including Yang Liu and Yin Wang, who contribute to the research and development of cancer therapies.
Conclusion
Pan Zeng's innovative approach to treating hematologic cancers through HIF inhibitors showcases his dedication to advancing medical science. His work has the potential to significantly impact cancer treatment and improve the lives of patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile